Related Experiment Video
Updated: Jun 1, 2025
Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats
Published on: March 11, 2016
Diagnostic Accuracy of Furosemide Stress Test and Cystatin-C for Predicting Acute Kidney Injury Progression in
S Dyvik1, Nisha Toteja2, Aliza Mittal1
1Department of Pediatrics, All India Institute of Medical Sciences, Jodhpur, India.
Insights
The furosemide stress test (FST) effectively predicts acute kidney injury (AKI) progression in children, showing comparable accuracy to cystatin-C levels. This bedside tool aids in assessing tubular dysfunction and the need for kidney replacement therapy (KRT).
Area of Science:
- Pediatric Nephrology
- Critical Care Medicine
- Diagnostic Biomarkers
Background:
- Acute kidney injury (AKI) is a significant concern in pediatric intensive care units (PICUs).
- Early identification of AKI progression and the need for kidney replacement therapy (KRT) is crucial for patient outcomes.
- The furosemide stress test (FST) and cystatin-C are potential biomarkers for assessing kidney function.
Purpose of the Study:
- To evaluate the predictive performance of the furosemide stress test (FST), serum cystatin-C, and urine cystatin-C.
- To identify children at risk of progressing to stage-3 AKI and requiring KRT.
- To compare the diagnostic accuracy of FST with cystatin-C levels in pediatric AKI.
Main Methods:
- A cohort of children (1 month to 18 years) with KDIGO stage-1/2 AKI admitted to the PICU were enrolled.
- Furosemide stress tests (FST) and serum and urine cystatin-C levels were measured.
- Primary outcome was progression to stage-3 AKI; secondary outcomes included KRT need, length of stay, and mortality.
Main Results:
- Of 41 children, 17.07% progressed to stage-3 AKI.
- FST at 6 hours demonstrated high predictive value (AUROC 0.87).
- Urine cystatin-C showed high sensitivity (100%) and AUROC (0.91) for predicting stage-3 AKI.
Conclusions:
- The furosemide stress test (FST) is a valuable bedside tool for predicting AKI progression and tubular dysfunction in children.
- FST demonstrates diagnostic accuracy comparable to urine and serum cystatin-C.
- Further research in larger cohorts is recommended for enhanced generalizability.
Objectives:
To evaluate the predictive ability of furosemide stress test (FST), serum and urine cystatin-C in identifying progressive acute kidney injury (AKI) and the need for kidney replacement therapy (KRT).
Methods:
Children aged one month to 18 y admitted in the pediatric intensive care unit (PICU) with Kidney Diseases Improving Global Outcomes (KDIGO) stage-1/2 AKI were enrolled. FST and serum and urine cystatin-C levels were performed and analyzed. The primary outcome was progression to stage-3 AKI. Secondary outcomes included comparing predictive ability of FST vs. cystatin-C for stage-3 AKI and need for KRT, adverse effects, length of hospital stay and mortality.
Results:
Of the 41 children enrolled, seven (17.07%) progressed to KDIGO stage-3 AKI. Four children were furosemide non-responders at 2 h and five at 6 h post-FST. The sensitivity, specificity and area under the receiver operating characteristic curve (AUROC) of FST at 2 h were 57.14%, 100% and 0.84 (p = 0.01), and at 6 h were 71.43%, 100% and 0.87 (p < 0.001), respectively. Urine cystatin-C was positive in 20 (48.78%) children, of which seven progressed to stage-3 AKI [sensitivity- 100%, specificity- 61.76%, AUROC- 0.91 (p = 0.003)]. Five of nine children with positive serum cystatin-C progressed to stage-3 AKI [sensitivity- 71.43%, specificity- 88.24%, AUROC- 0.75 (p = 0.08)]. All FST non-responders progressed to undergo KRT showing sensitivity and specificity of 66.67% and 100% at 2 h (AUROC- 0.87) and 85% and 100% at 6 h (AUROC- 0.89) respectively.
Conclusions:
FST is a simple bedside tool with robust predictive value in detecting kidney impairment progression in children and can be utilized in PICU for assessing tubular dysfunction. The diagnostic accuracy of FST was comparable to that of urine and serum cystatin-C. Further studies can be done on a larger cohort for better generalizability.
Related Concept Videos
01:17Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
01:27Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
01:11Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:23Renal Clearance
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
01:10Nephrons
01:45Kidney Structure